Inactivation efficacy of low-pressure plasma treatment against seed-borne tomato pathogen Clavibacter michiganensis and effect of seed setting position and mesh sheet usage
Journal of Microorganism Control · 2023
DOI: 10.4265/jmc.28.3_123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Microorganism Control, 2023. Verfasst von Terumi Nishioka und 6 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute of Environment, Agriculture and Fisheries, Osaka Prefecture. Hauptthemen laut MEDLINE: Micrococcaceae, Actinobacteria, Solanum lycopersicum. Die Arbeit nennt 20 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Research Institute of Environment, Agriculture and Fisheries, Osaka Prefecture.
- Present address: Industrial Technology Center of Nagasaki.
- Saga University.
Zitieren
APA
Nishioka, T., Takai, Y., Mishima, T., Tanimoto, H., Okada, K., Misawa, T., & Kusakari, S. (2023). Inactivation efficacy of low-pressure plasma treatment against seed-borne tomato pathogen Clavibacter michiganensis and effect of seed setting position and mesh sheet usage. Journal of Microorganism Control. https://doi.org/10.4265/jmc.28.3_123
Vancouver
Nishioka T, Takai Y, Mishima T, Tanimoto H, Okada K, Misawa T, et al. Inactivation efficacy of low-pressure plasma treatment against seed-borne tomato pathogen Clavibacter michiganensis and effect of seed setting position and mesh sheet usage. Journal of Microorganism Control. 2023. doi:10.4265/jmc.28.3_123
BibTeX
@article{Nishioka2023,
author = {Nishioka, Terumi and Takai, Yuichiro and Mishima, Tomoko and Tanimoto, Hideo and Okada, Kiyotsugu and Misawa, Tatsuya and Kusakari, Shinichi},
title = {Inactivation efficacy of low-pressure plasma treatment against seed-borne tomato pathogen Clavibacter michiganensis and effect of seed setting position and mesh sheet usage},
journal = {Journal of Microorganism Control},
year = {2023},
doi = {10.4265/jmc.28.3_123}
}
EUVIMED